International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
Irvine, California and Amsterdam (ots/PRNewswire) - Panel's Recommendations Reinforce Clinical Value of Tests Such as BluePrint(R) Agendia, a commercial-stage molecular cancer diagnostics company, today announced that the 12th St. Gallen International Breast Cancer Conference (2011) Expert Panel's recommendations ...